| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
|
N Engl J Med
|
2015
|
19.14
|
|
2
|
In-center hemodialysis six times per week versus three times per week.
|
N Engl J Med
|
2010
|
10.73
|
|
3
|
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
|
N Engl J Med
|
2002
|
10.52
|
|
4
|
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
|
JAMA
|
2008
|
7.50
|
|
5
|
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
|
Kidney Int
|
2013
|
3.09
|
|
6
|
Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO.
|
Am J Kidney Dis
|
2009
|
2.61
|
|
7
|
Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients.
|
Am J Kidney Dis
|
2007
|
2.39
|
|
8
|
Treatment center and geographic variability in pre-ESRD care associate with increased mortality.
|
J Am Soc Nephrol
|
2009
|
2.21
|
|
9
|
Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
|
Clin J Am Soc Nephrol
|
2011
|
2.19
|
|
10
|
Effect of frequent hemodialysis on residual kidney function.
|
Kidney Int
|
2013
|
2.10
|
|
11
|
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.
|
J Am Soc Nephrol
|
2005
|
2.07
|
|
12
|
Risk of vascular access complications with frequent hemodialysis.
|
J Am Soc Nephrol
|
2013
|
1.93
|
|
13
|
Relationship between volume status and blood pressure during chronic hemodialysis.
|
Kidney Int
|
2002
|
1.93
|
|
14
|
Potential cost savings of erythropoietin administration in end-stage renal disease.
|
Am J Med
|
2002
|
1.83
|
|
15
|
Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.
|
Clin J Am Soc Nephrol
|
2012
|
1.75
|
|
16
|
Recruitment and training for home hemodialysis: experience and lessons from the Nocturnal Dialysis Trial.
|
Clin J Am Soc Nephrol
|
2010
|
1.64
|
|
17
|
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
|
Kidney Int
|
2012
|
1.59
|
|
18
|
Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project.
|
J Am Soc Nephrol
|
2003
|
1.58
|
|
19
|
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study.
|
J Am Soc Nephrol
|
2003
|
1.56
|
|
20
|
Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance.
|
Kidney Int
|
2010
|
1.43
|
|
21
|
Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?
|
Kidney Int
|
2005
|
1.22
|
|
22
|
Gene-gene interactions in APOL1-associated nephropathy.
|
Nephrol Dial Transplant
|
2013
|
1.21
|
|
23
|
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
|
Nephrol Dial Transplant
|
2011
|
1.18
|
|
24
|
Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.
|
Am J Kidney Dis
|
2011
|
1.10
|
|
25
|
Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study.
|
J Ren Nutr
|
2003
|
1.09
|
|
26
|
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2007
|
1.07
|
|
27
|
Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.
|
Hum Pathol
|
2010
|
1.05
|
|
28
|
The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis.
|
J Am Geriatr Soc
|
2008
|
1.05
|
|
29
|
Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.
|
Semin Dial
|
2008
|
1.00
|
|
30
|
Diabetes is the strongest risk factor for lower-extremity amputation in new hemodialysis patients.
|
Diabetes Care
|
2004
|
0.99
|
|
31
|
Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study.
|
Nephrol Dial Transplant
|
2005
|
0.96
|
|
32
|
Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States.
|
Am J Kidney Dis
|
2009
|
0.96
|
|
33
|
Disparity in outcomes for adult Native American hemodialysis patients? Findings from the ESRD Clinical Performance Measures Project, 1996 to 1999.
|
Kidney Int
|
2004
|
0.95
|
|
34
|
Changes in anthropometry and mortality in maintenance hemodialysis patients in the HEMO Study.
|
Am J Kidney Dis
|
2013
|
0.93
|
|
35
|
Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.
|
Semin Dial
|
2008
|
0.92
|
|
36
|
Correlates of sleep behavior among hemodialysis patients. The kidney outcomes prediction and evaluation (KOPE) study.
|
Am J Nephrol
|
2002
|
0.89
|
|
37
|
Predictors of central venous catheter use at the initiation of hemodialysis.
|
Semin Dial
|
2008
|
0.87
|
|
38
|
Differences in intermediate outcomes for Asian and non-Asian adult hemodialysis patients in the United States.
|
Kidney Int
|
2003
|
0.86
|
|
39
|
Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus.
|
J Cardiovasc Magn Reson
|
2014
|
0.85
|
|
40
|
Is nutritional status associated with self-reported sleep quality in the HEMO study cohort?
|
J Ren Nutr
|
2011
|
0.81
|
|
41
|
Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
|
Pharmacotherapy
|
2010
|
0.80
|
|
42
|
Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers.
|
BMC Nephrol
|
2013
|
0.79
|
|
43
|
Ethnicity, medical insurance, and living kidney donation.
|
Clin Transplant
|
2013
|
0.79
|
|
44
|
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study.
|
Am J Kidney Dis
|
2006
|
0.79
|
|
45
|
Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes.
|
Kidney Int
|
2013
|
0.79
|
|
46
|
Multiple factors affect renal dietitians' use of the NKF-K/DOQI Adult Nutrition Guidelines.
|
J Ren Nutr
|
2005
|
0.77
|
|
47
|
A decade after the KDOQI CKD guidelines: impact on NKF-KDOQI.
|
Am J Kidney Dis
|
2012
|
0.76
|
|
48
|
Effects of reduced intradialytic urea generation rate and residual renal clearance on modeled urea distribution volume and Kt/V in conventional, daily, and nocturnal dialysis.
|
Semin Dial
|
2010
|
0.76
|
|
49
|
Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients.
|
J Ren Nutr
|
2010
|
0.75
|
|
50
|
Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service.
|
Am J Kidney Dis
|
2002
|
0.75
|
|
51
|
The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials.
|
Blood Purif
|
2016
|
0.75
|
|
52
|
Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice?
|
Curr Opin Nephrol Hypertens
|
2011
|
0.75
|